Skip to main content
OpenTrials
Completed

NCT Number: NCT03097393

Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis

The aim of this study is to examine if procalcitonin (PCT) can be used for early prediction of AKI septic patients in ICU.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Kidney Injury Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Renal Insufficiency Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

67 patients with sepsis were enrolled in this study. On admission, PCT was measured together with serum creatinine, urea, and other inflammatory markers. Quick Sepsis-related Organ Failure Assessment was calculated at the emergency department. Patients were classified into those with Acute kidney injury (AKI) and non-AKI groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ICU patients with sepsis

Exclusion criteria

  • Patient known to have End-stage kidney disease
  • Patients on Renal replacement therapy
  • patients without procalcitonin level within 24 hours from admission.

Treatment and study plan

measure Serum procalcitonin level

Diagnostic Test

measuring procalcitonin level

Primary outcomes

  1. development of AKI

    Time frame: 28 Days

    elevated kidney functions creatinine or oliguria

Sponsors and collaborators

Lead sponsor

Benha University

Other

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Mar 31, 2017
Registry last updated
Mar 31, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.